RUBEN HERNAEZ to Cohort Studies
This is a "connection" page, showing publications RUBEN HERNAEZ has written about Cohort Studies.
Connection Strength
0.336
-
Reply to: "Prevalence and short-term mortality in a national US cohort with acute-on-chronic liver failure". J Hepatol. 2019 09; 71(3):638-639.
Score: 0.084
-
Reply to: "Mortality of acute-on-chronic liver failure: What is the role of obesity?" J Hepatol. 2019 06; 70(6):1301-1302.
Score: 0.082
-
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
Score: 0.081
-
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4.
Score: 0.025
-
Antitumour necrosis factor-a agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ Open Gastroenterol. 2020; 7(1):e000349.
Score: 0.022
-
Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis. Pancreatology. 2016 Nov - Dec; 16(6):966-972.
Score: 0.017
-
Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology. 2013 Sep; 58(3):966-75.
Score: 0.014
-
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011 Mar; 7(3):e1001324.
Score: 0.012